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Abstract
Background: C-reactive protein (CRP) has emerged as
an important predictor for cardiovascular disease
(CVD). To facilitate clinical and public health interven-
tions, CRP thresholds have been defined as follows:
low-risk (-1.0 mg/L), average-risk (1.0–3.0 mg/L), and
high-risk ()3.0 mg/L). However, these cut-off thresh-
olds are based on distributions in Western popula-
tions, and do not distinguish between men and
women.
Methods: We examined CRP distribution, gender dif-
ference, and determinants of CRP concentrations
ranging from 0.02 mg/L to 10.0 mg/L, in 4923 Korean
adults (2248 men; 2675 women) who received health
checkups at Gangnam Severance Hospital from
March 2006 to May 2007.
Results: The distribution of CRP was highly skewed
toward lower concentrations. CRP was higher in men
than women, and the cut-off thresholds for the high-
risk tertile of CRP concentrations corresponded to
1.01 mg/L in men and 0.62 mg/L in women, based on
the current study population. Age, male gender, cig-
arette smoking, physical activity, body mass index,
total cholesterol, high density lipoprotein cholesterol,
g-glutamyltransferase, and uric acid were indepen-
dently associated with CRP concentrations.
Conclusions: CRP distribution and gender difference
in Korean adults were found to be different from pre-
vious Western studies, although similar risk factors
influence CRP concentrations. Our results suggest
that ethnicity and gender specific cut-off thresholds
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for CRP concentrations should be taken into consid-
eration in CVD risk assessment.
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Introduction
Increasing evidence reveals that arterial inflammation
plays a key role in the process of atherosclerosis and
cardiovascular disease (CVD) (1, 2). Recent studies
have shown that C-reactive protein (CRP) is not just
an indicator of current infection, but also a useful
predictor of CVD incidence and mortality (3–5). Thus,
early detection of a continuous increase in CRP con-
centrations may be useful in predicting subsequent
development of CVD. Recently, the Centers for Dis-
ease Control and Prevention (CDC) and American
Heart Association (AHA) recommended that measure-
ment of CRP level is useful to assess risk of primary
and secondary cardiovascular events (6). To facilitate
clinical and public health interventions, CRP thresh-
olds have been defined as follows: low-risk (-1.0
mg/L), average-risk (1.0–3.0 mg/L), and high-risk ()3.0
mg/L). These correspond to approximate tertiles of
CRP in the US adult population (6). Despite the car-
diovascular health implications of CRP, the recom-
mended cut-off points of the CDC/AHA are based
predominantly on Western populations, and do not
make a distinction between men and women. Gender
differences in CRP concentrations is currently a con-
troversial topic. Some epidemiological studies have
reported similar values for CRP in both men and
women (7, 8), whereas others have shown higher
concentrations in men (9) or women only (10, 11).
On the basis of these considerations, it is critical to
know the characteristics and conditions associated
with increased or decreased CRP concentrations in
specific populations, but relatively little information is
known about East Asians. Koreans are a group of East
Asians with ethnic homogeneity and lower body
mass index (BMI) compared to Westerners. In addi-
tion, the smoking rate for Korean women is -5%,
which is strikingly lower than for Korean men (12).
Indeed, different ethnicity and lifestyle factors of
Koreans may affect the inflammatory response in
different ways (13–15).
Therefore, we examined gender difference and
determinants of CRP concentrations in 4923 Korean
adults (2248 men; 2675 women; aged 20–75 years)
who received health checkups at Gangham Severance
Hospital from March 2006 to May 2007.
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Materials and methods
Study population
This study is based on the Health Risk Assessment Study
(HERAS) cohort. The HERAS consisted of 5342 subjects (2347
men, 2995 women) who visited voluntarily the Health Pro-
motion Center, Gangnam Severance Hospital, for a routine
health checkup. This cohort aims to characterize the preva-
lence and distribution of CVD risk factors and explore sur-
rogate markers for CVD in Korean adults (16). Between
March 2006 and May 2007, 6451 individuals gave written
informed consent to the study protocol at the beginning and
at follow-up. The study was approved by the Institutional
Review Board of Yonsei University College of Medicine,
Seoul, Korea. Subjects meeting any of the following criteria
were excluded: CRP concentrations of more than 10 mg/L for
ruling out potential ongoing infection or inflammatory dis-
orders (ns38); a history of cancer, ischemic heart disease,
stroke, respiratory, renal, liver, and rheumatologic disease
(ns158); and use of oral contraceptives or hormone replace-
ment therapy (ns223). After exclusion, the remaining 4923
subjects (2248 men; 2675 women; aged 20–75 years), whose
CRP concentrations ranged from 0.02–10.0 mg/L, were
included in the final analysis.
Data collection
Physical examinations were performed by trained medical
staff according to a standardized procedure. Body weight
and height were measured in subjects wearing light indoor
clothing and without shoes to the nearest 0.1 kg and 0.1 cm,
respectively. BMI was calculated as the ratio of weight (kg)/
height (m2). Participants were asked about health related
behaviors including cigarette smoking, alcohol consump-
tion, and physical activity as well as current treatment for
any type of disease. If subjects were receiving treatment,
they were asked for the date of diagnosis of disease and a
list of medications taken. Following a 12-h overnight fast,
blood samples were obtained from the antecubital vein of
each subject. High sensitivity CRP concentrations were
measured using the Roche/Hitachi 912 System (Roche Diag-
nostics, Indianapolis, IN, USA), a latex-enhanced immuno-
turbidimetric method with a lower limit of detection of 0.02
mg/L. The normal range of CRP concentrations could be dif-
ferent among different ethnic groups and the upper refer-
ence range limit of CRP in Korean adults is 6.0 mg/L. Fasting
plasma glucose (FPG), total cholesterol, triglyceride, high
density lipoprotein (HDL) cholesterol, aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), g-glutamyl-
transferase (GGT), and uric acid were measured using a
Hitachi 7600-110 Chemistry analyzer (Hitachi, Tokyo, Japan).
Diabetes was defined as a self-reported history of the dis-
order or an FPG concentration G7.0 mmol/L. Hypertension
was defined as a self-reported history of the disorder, sys-
tolic blood pressure (SBP) G140 mm Hg, or diastolic blood
pressure (DBP) G90 mm Hg.
Statistical analysis
Clinical and chemical characteristics of the study population
were summarized. Comparisons between men and women
were performed using Student’s t-test for continuous
variables, and the x2-test was used for categorical variables.
The median concentration of CRP between men and women
was tested using the Wilcoxon-Rank sum test. Age and mul-
tivariate adjusted geometric mean values of CRP concentra-
tions in men and women were calculated using analysis of
covariance (ANCOVA). To confirm that gender differences in
CRP were independent of the effects of smoking, we also
compared multivariate adjusted geometric mean values of
CRP concentrations between men and women through sub-
group analyses of non-smokers using ANCOVA test. We
determined the percentage of people classified as being low-
risk (-1 mg/L), intermediate-risk (1–3 mg/L), and high-risk
()3 mg/L) using the CRP risk criteria of the CDC/AHA sci-
entific statement (6). Due to skewness, CRP was log trans-
formed prior to statistical analyses. Pearson correlation
coefficients were determined for CRP concentrations in men
and women vs. age, BMI, cigarette smoking, alcohol use,
physical activity, SBP, DBP, FPG, total cholesterol, triglycer-
ide, HDL cholesterol, and uric acid. To examine independent
correlates of CRP, a multivariate linear regression model was
constructed with log-transformed CRP as the dependent
variable. All analyses were performed using SAS statistical
software, version 9.1 (SAS Institute Inc, Cary, NC, USA). All
statistical tests were two-sided and a p-0.05 was used for
statistical significance.
Results
Table 1 shows the demographics of the study popu-
lation, which consisted of 2248 men and 2675 women.
The mean BMI (kg/m2) was 24.7 for men and 23.0 for
women. Blood pressure, FPG, total cholesterol, tri-
glyceride, and liver enzymes were higher in men com-
pared with women. Cigarette smoking and alcohol
use were substantially more common in men than in
women, and the percentage of hypertension and dia-
betes was also more prevalent in men.
The overall distribution of CRP according to age
group and gender is shown in Table 2. The median
value of CRP increased with age in both men and
women. Men had higher CRP concentrations than
women (median, 0.72 mg/L vs. 0.45 mg/L; p-0.001),
and this pattern was observed for all age groups.
Gender differences in CRP concentrations remained
valid after adjusting for age, BMI, smoking status,
alcohol intake, physical activity, blood pressure, FPG,
total cholesterol, triglyceride, and HDL cholesterol.
The multivariate adjusted geometric mean CRP con-
centrations were 0.67 mg/L in men and 0.57 mg/L in
women (p-0.001, Figure 1). However, the current
study failed to show any significant gender differenc-
es in CRP concentrations through subgroup analyses
of non-smokers. After adjustment for age, BMI, alco-
hol intake, physical activity, blood pressure, FPG, total
cholesterol, triglyceride and HDL cholesterol, the gen-
der difference was attenuated and not significant in
subgroup analyses of non-smokers (ps0.090).
The proportion of subjects with high-risk CRP con-
centrations according to the CDC/AHA cut-off thresh-
old of )3.0 mg/L was 8.7% in men and 5.9% in
women. Similarly, the proportion of subjects with
intermediate-risk CRP concentrations of 1.0–3.0 mg/L
was also higher in men compared to women (28.3%
vs. 18.1%) (Table 3).
Pearson and Spearman correlation results are
shown in Table 4. Log transformed CRP concentra-
tions correlated significantly with age, BMI, blood
pressure, FPG, uric acid, total cholesterol, triglyceride,
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Table 1 Demographic and biochemical characteristics of the study populationa.
Men Women p-Valueb
n 2248 2675
Age, years 46.6"10.1 45.3"10.7 -0.001
BMI, kg/m2 24.7"2.9 23.2"3.2 -0.001
SBP, mm Hg 125.9"15.3 121.3"16.0 -0.001
DBP, mm Hg 78.7"10.1 74.9"10.3 -0.001
FPG, mmol/L 5.32"1.08 4.93"0.81 -0.001
Total cholesterol, mmol/L 4.80"0.81 4.74"0.84 0.011
HDL cholesterol, mmol/L 1.27"0.27 1.48"0.33 -0.001
Triglyceride, mmol/L 1.4 (1.0–2.1) 1.0 (0.7–1.4) -0.001
AST, U/L 22.7"7.9 19.6"6.3 -0.001
ALT, U/L 26.3"15.8 17.2"10.0 -0.001
GGT, U/L 31 (21–48) 15 (12–20) -0.001
Uric acid, mmol/L 344.7"71.5 249.1"55.1 -0.001
CRP concentration, mg/L
Arithmetic mean, mg/L 1.17"1.34 0.84"1.20 -0.001
Geometric mean, mg/L 0.76"2.48 0.49"2.60 -0.001
Median, mg/L 0.72 (0.40–1.43) 0.45 (0.25–0.98) -0.001
Current smoking, % 40.7 5.3 -0.001
Alcohol ingestionc, % 51.3 7.5 -0.001
Physical activityd, % 28.1 50.9 -0.001
Hypertensione, % 32.1 22.8 -0.001
Diabetesf, % 6.7 3.4 -0.001
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high
density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, g-glutamyltransferase; CRP, C-
reactive protein. aValues are presented as mean"SD, median (interquartile range), or percentage; bp-value was calculated by
comparing men and women using t-test, Wilcoxon-Rank sum test, or x2-test; calcohol drinking G20 g/day; dregular exerci-
seGonce/week; ehypertension was defined as SBPG140 mm Hg, and/or DBPG90 mm Hg, or history of the disorder; fdiabetes
was defined as fasting plasma glucose level G7.0 mmol/L or a history of the disorder.
Table 2 Distribution of CRP concentration by age group and gender.
n Percentile
5 10 25 50 75 90 95
Men, years
-40 575 0.18 0.23 0.38 0.67 1.42 2.47 4.39
40–49 846 0.20 0.25 0.41 0.71 1.46 2.82 4.10
50–59 575 0.21 0.26 0.41 0.72 1.36 2.45 3.94
G60 252 0.23 0.29 0.47 0.85 1.62 3.55 5.32
Total 2248 0.19 0.25 0.40 0.72 1.43 2.71 4.16
Women, years
-40 838 0.11 0.13 0.20 0.34 0.66 1.53 2.76
40–49 926 0.13 0.15 0.23 0.38 0.82 1.76 2.65
50–59 639 0.17 0.22 0.33 0.61 1.29 2.60 4.72
G60 272 0.19 0.25 0.39 0.72 1.73 3.10 4.17
Menopause (–) 1746 0.12 0.15 0.21 0.35 0.63 1.26 1.95
Menopause (q) 929 0.17 0.21 0.32 0.59 1.45 3.08 4.45
Total 2675 0.13 0.16 0.25 0.45 0.98 2.14 3.62
The percentiles are calculated from each subgroup.
and HDL cholesterol for both men and women,
whereas cigarette smoking correlated only in men. In
multivariate regression analysis, age, male gender,
cigarette smoking, physical activity, BMI, total choles-
terol, HDL cholesterol, GGT, and uric acid were posi-
tively associated with CRP concentrations, whereas
physical activity and HDL cholesterol were inversely
associated with CRP concentrations (Table 5).
Discussion
In this cross-sectional study, we examined gender dif-
ferences and determinants of CRP concentrations in
Korean adults. The distribution of CRP was highly
skewed toward lower concentrations with long right
tail. Although ;30% of the US population has CRP
concentrations )3 mg/L (6), only 8.7% of men and
5.9% of women were found to fall into the high-risk
category with CRP concentrations )3.0 mg/L. This
finding suggests that CRP is lower in Korean adults,
which might explain the lower coronary disease event
rate in Korea. As previously mentioned, the CDC and
AHA have recommended categorizing subjects using
CRP cut-off thresholds of -1.0, 1.0–3.0, and )3.0
mg/L into low-, average-, and high-risk categories,
respectively. These recommendations are based pri-
marily on findings obtained from Western popula-
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Figure 1 Adjusted geometric mean CRP level in men and women for the entire study population (A) and non-smokers (B).
aAdjusted for age, BMI, smoking status, alcohol intake, exercise, blood pressure, fasting plasma glucose, total cholesterol,
triglyceride and HDL cholesterol; badjusted for age, BMI, alcohol intake, physical activity, blood pressure, fasting plasma
glucose, total cholesterol, triglyceride and HDL cholesterol; bars show mean standard errors.
Table 3 Proportion of subjects with low-, intermediate-, and
high-risk CRP concentrations according to the CDC/AHD cut-
off thresholds.
n, % CRP categories
-1.0 mg/L 1.0–3.0 mg/L )3.0 mg/L p-Valuea
Total 3448 (70.1) 1117 (22.7) 353 (7.2) -0.001
Men 1418 (63.1) 635 (28.3) 195 (8.7)
Women 2033 (76.0) 484 (18.1) 158 (5.9)
CRP, C-reactive protein. ap-Value was calculated by compar-
ing men and women using x2-test.
tions. Although the study population is not
representative of the general population of Korea, the
cut-off threshold for the high-risk tertile of CRP con-
centrations corresponds to 1.01 mg/L in men and
0.62 mg/L in women, based on the current study pop-
ulation. Some observational studies have shown that
CRP concentrations are lower in East Asians com-
pared with Westerners. Multiethnic studies in the US
and Canada have shown that Chinese and Japanese
have lower CRP concentrations compared to Western
and aboriginal populations (17, 18). Several observa-
tional studies suggest that CRP concentrations may
be lower in East Asians compared to Westerners. Lee
et al. (16) reported that the Chinese had the lowest
CRP concentrations when compared to Caucasians,
African Americans, and Hispanics. In another multi-
ethnic study in Canada, Anand et al. (17) suggested
that the Chinese had the lowest median CRP concen-
trations (0.69 mg/L) when compared to European
(1.24 mg/L), South Asian (1.80 mg/L), and aboriginal
populations (4.20 mg/L) in Canada. Similar results
were reported by the Study of Women’s Health
Across the Nation (SWAN) cohort in the US where
Chinese (0.7 mg/L) and Japanese (0.5 mg/L) had lower
median CRP concentrations compared with Cauca-
sians (1.4 mg/L), African Americans (3.0 mg/L), and
Hispanics (2.3 mg/L) (17). These ethnic differences in
CRP concentrations may be explained by genetic pol-
ymorphisms, diet, and lifestyle differences, which
have been shown to affect inflammatory response
(10–13, 19).
In the present study, CRP concentrations were high-
er in men compared with women, suggesting that
male gender is a strong independent determinant of
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Table 4 Correlation between log-transformed CRP and various parameters.
Men Women
r p-Value r p-Value
Age, years 0.063 0.002 0.259 -0.001
BMI, kg/m2 0.267 -0.001 0.385 -0.001
SBP, mm Hg 0.060 0.004 0.140 -0.001
DBP, mm Hg 0.068 0.001 0.130 -0.001
FPG, mmol/L 0.075 -0.001 0.206 -0.001
Total cholesterol, mmol/L 0.054 0.009 0.183 -0.001
HDL cholesterol, mmol/L –0.264 -0.001 –0.263 -0.001
Triglyceride, mmol/L 0.146 -0.001 0.298 -0.001
AST, U/L 0.147 -0.001 0.188 -0.001
ALT, U/L 0.177 -0.001 0.216 -0.001
GGT, U/L 0.209 -0.001 0.128 -0.001
Uric acid, mmol/L 0.205 -0.001 0.274 -0.001
Current smoker, % 0.122 -0.001 0.221 0.221
Alcohol ingestiona, % –0.042 0.045 –0.036 0.927
Physical activityb, % 0.030 0.149 0.018 0.056
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high
density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, g-glutamyltransferase; CRP, C-
reactive protein. aAlcohol drinking G20 g/day; bregular exercise Gonce/week. Coefficients (r) and p-value were calculated
using Pearson’s correlation analysis for continuous variables and Spearman-Rank correlation for cigarette smoking, alcohol
ingestion, and physical activity.
Table 5 Results of multiple linear regression analysis to assess independent relationships between log-transformed CRP
and clinical variablesa.
Variables Parameter, b SE p-Value
Age, per 10 years 0.099 0.014 -0.001
Male gender 0.127 0.038 -0.001
BMI, kg/m2 0.060 0.005 -0.001
Current smoking 0.132 0.039 -0.001
Physical activityb –0.061 0.027 0.027
FPG, mmol/L 0.032 0.014 0.023
Total cholesterol, mmol/L 0.067 0.017 -0.001
HDL cholesterol, mmol/L –0.584 0.050 -0.001
GGT, per 10 U/L 0.056 0.008 -0.001
Uric acid, per 10 mmol/L 0.020 0.002 -0.001
BMI, body mass index; FPG, fasting plasma glucose; HDL, high density lipoprotein; GGT, g-glutamyltransferase. Variables
significantly associated with CRP concentrations are shown in the table. aMultivariate linear regression analysis included age,
gender, BMI, SBP, DBP, fasting plasma glucose, total cholesterol, HDL cholesterol, triglycerides, AST, ALT, GGT, uric acid,
current history of cigarette smoking and alcohol ingestion, and physical activity as independent variables; bregular exerci-
seGonce/week.
CRP concentrations. There is conflicting evidence
concerning relative CRP concentrations in men and
women. Some data from European populations have
shown similar CRP concentrations in men and women
(8, 20). In that study, the median CRP concentrations
in men and women were similar (men, 1.52 mg/L;
women, 1.50 mg/L). Data from Northern European
populations (France, West Germany, and Scotland)
and Southern European populations (Spain and Med-
iterranean countries) have also shown similar distri-
butions of CRP concentrations with a median of
1.5 mg/L for both genders (8, 19). On the contrary, in
two large multiethnic studies in the US, women had
higher CRP concentrations, irrespective of race (9, 21).
To date, relatively little has been written regarding the
comparison of gender differences in CRP concentra-
tions among East Asians. Yamada et al. reported in a
Jichi Medical School Cohort Study, consisting of 2275
men and 3832 women in Japan, that men have higher
CRP concentrations (9). Consistent with the results
seen in Japanese, men in the current study have high-
er CRP concentrations compared with women. An
observational study of Chinese subjects showed no
difference in CRP concentrations with respect to gen-
der (22). Contrary to our study and the Jichi Medical
School study, the Chinese cohort was comprised of
older men and women aged 50–70 years. Therefore,
the relatively higher proportion of postmenopausal
women may have influenced CRP concentrations.
Although the reason for these discrepancies in CRP
concentrations with respect to gender is unclear,
there are some possible explanations. Differences in
lifestyle and metabolic risk factors between men and
women in each study population may affect CRP con-
centrations. In fact, in our study, men usually had
more undesirable risk factors for atherosclerosis such
as cigarette smoking, alcohol intake, obesity, hyper-
tension, and diabetes when compared to women.
These risk factors can be important contributors to
chronic low-grade inflammation. Although gender dif-
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ferences with respect to CRP concentrations remained
valid in multivariate adjusted ANCOVA test, there
appeared to be no significant difference in the sub-
group analyses for non-smokers. This suggests that
gender differences may not be due to gender itself,
but rather a reflection of different cardiovascular risk
factors. In addition, the proportion of patients using
estrogen was different in each study population. CRP
is known to be increased in women taking estrogen
(23). To avoid the confounding factor of drug use,
subjects taking estrogen replacement therapy or oral
contraceptives were excluded from our study.
In the multivariate model, CRP concentrations were
significantly associated with several metabolic
variables including BMI, total cholesterol, and HDL
cholesterol. These findings are consistent with current
knowledge regarding metabolic disturbances and
inflammatory markers (10–12). The positive associa-
tion of CRP with BMI may be explained by the effects
of proinflammatory cytokines including interleukin-6
(IL-6) and tumor necrosis factor-a (TNF-a), which are
expressed in adipose tissue and stimulate hepatic
production of CRP (24, 25). Several mechanisms may
explain the significant relationship between cigarette
smoking and CRP concentrations. Cigarette smoking
promotes inflammation in the oral cavity and airway
tract, leading to periodontitis and chronic bronchitis
(26, 27). Also, free radicals generated by cigarette
smoking can induce the production of inflammatory
cytokines and consequently elevate CRP concentra-
tions, as mentioned earlier (28). We also found an
inverse relationship between CRP and physical activ-
ity. Regular exercise may have a favorable effect on
suppressing abdominal fat accumulation and inflam-
matory markers (29). Serum CRP concentrations were
also associated with biomarkers such as serum GGT
and uric acid, which are known to be surrogate mark-
ers of adverse cardiovascular events and mortality
(16, 30). This finding is consistent with emerging evi-
dence that increased GGT and uric acid are strongly
linked to chronic low-grade inflammation (16, 30).
There are several limitations of the current study.
First, because study subjects were volunteers for
health promotion screening at a single hospital, and
appeared to be slightly healthier compared to
community-based cohorts, the study population may
not be representative of the general Korean popula-
tion. Therefore, this study may have been affected by
the selection bias. Second, the CDC and AHA guide-
lines recommend two separate CRP measurements
for determining within individual variability (6). How-
ever, only one measurement of CRP was included in
the analysis and it was not possible to determine
whether an acute and brief episode of infection or
chronic inflammation was responsible for the corre-
lation observed. To minimize these random errors, we
excluded subjects with CRP values G10 mg/L. Third,
we lacked information on the measurement of
abdominal adiposity and waist circumference. Con-
sequently, we could not determine exactly whether
the association of CRP with BMI depended on overall
adiposity or distribution pattern. Finally, we did not
take into consideration the effect of other potential
confounding variables on CRP concentrations such
as socioeconomic status, diet pattern, medication
history and use of potential anti-inflammatory agents
waspirin, other non-steroidal anti-inflammatory drugs
(NSAIDs), angiotensin-converting enzyme (ACE)
inhibitors, and 3-hydroxy-3-methylglutaryl coenzyme
A (HMG-CoA) reductase inhibitorsx.
Despite these limitations, given the increasing use
of CRP as a valuable predictor of CVD, our findings
may have important clinical implications in terms of
preventive cardiovascular risk strategies in Korea.
In summary, CRP distributions and gender differ-
ences in Koreans are different from previous Western
studies, although similar risk factors influence CRP
concentrations. Our results suggest that ethnicity and
gender specific cut-off thresholds for CRP should be
taken into consideration in CVD risk assessment.
Future prospective studies are warranted to assess
how different CRP distributions influence CVD risk
prediction in Korean adults.
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